Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (41-50 of 373) with videos related to

Pageof 38
Sort By:
Current Hematology Reports|October 20, 2005
CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemiaIain C Macdougall
Contributions to Nephrology|May 25, 2006
How to optimise anaemia therapy in peritoneal dialysis patientsIain C Macdougall
Clinical Kidney Journal|December 12, 2017
Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directionsIain C Macdougall
Journal of Renal Care|November 7, 2009
Evolution of iv iron compounds over the last centuryIain C Macdougall
Current Medical Research and Opinion|January 27, 2004
Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than anotherIain C Macdougall
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 1, 2006
Postoperative tracheal rupture in a patient with a difficult airwayPeter C MacDougall
Kidney International. Supplement|March 20, 1999
Strategies for iron supplementation: oral versus intravenousI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2000
Intravenous administration of iron in epoetin-treated haemodialysis patients--which drugs, which regimen?I C Macdougall
Drugs|December 12, 2001
Darbepoetin Alfa: A Viewpoint by Iain C. MacdougallIain C. Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2001
An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)I C Macdougall
Pageof 38

Showing results (41-50 of 373) with videos related to

Sort By:
Pageof 38
Current Hematology Reports|October 20, 2005
CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemiaIain C Macdougall
Contributions to Nephrology|May 25, 2006
How to optimise anaemia therapy in peritoneal dialysis patientsIain C Macdougall
Clinical Kidney Journal|December 12, 2017
Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directionsIain C Macdougall
Journal of Renal Care|November 7, 2009
Evolution of iv iron compounds over the last centuryIain C Macdougall
Current Medical Research and Opinion|January 27, 2004
Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than anotherIain C Macdougall
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 1, 2006
Postoperative tracheal rupture in a patient with a difficult airwayPeter C MacDougall
Kidney International. Supplement|March 20, 1999
Strategies for iron supplementation: oral versus intravenousI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2000
Intravenous administration of iron in epoetin-treated haemodialysis patients--which drugs, which regimen?I C Macdougall
Drugs|December 12, 2001
Darbepoetin Alfa: A Viewpoint by Iain C. MacdougallIain C. Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2001
An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)I C Macdougall
Pageof 38